Literature DB >> 19695847

Incorporation methods for cholic acid chitosan-g-mPEG self-assembly micellar system containing camptothecin.

Tanasait Ngawhirunpat1, Nanthida Wonglertnirant, Praneet Opanasopit, Uracha Ruktanonchai, Rangrong Yoksan, Kaewkarn Wasanasuk, Suwabun Chirachanchai.   

Abstract

A water-insoluble anticancer agent, camptothecin (CPT) was incorporated to a polymeric micelle carrier system preparing from cholic acid chitosan-grafted poly (ethylene glycol) methyl ether (CS-mPEG-CA). CS-mPEG-CA formed a core-shell micellar structure with a critical micelle concentration (CMC) of 7.08 microg/ml. Incorporation efficiency was investigated by varying physical incorporation method and initial drug loading. Among three incorporation methods (dialysis, emulsion and evaporation methods), an emulsion method showed the highest CPT incorporation efficiency. Increasing the initial CPT loading from 5 to 40%, the incorporation efficiency decreased. In all examined CPT-loaded CS-mPEG-CA micelles, 5% initial drug loading showed the highest drug incorporation efficiency. Release of CPT from the micelles was sustained when increasing the initial CPT loading. This indicates the importance of incorporation method and the initial drug loading to obtain the optimum particle size with high drug loading and sustained drug release. When compared to the unprotected CPT, CPT-loaded CS-mPEG-CA micelles were able to prevent the hydrolysis of the lactone group of the drug. This novel CS-mPEG-CA polymer presents considerable potential interest in the further development of CPT carrier.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19695847     DOI: 10.1016/j.colsurfb.2009.07.027

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  4 in total

1.  Chitosan-based self-assembled nanocarriers coordinated to cisplatin for cancer treatment.

Authors:  Ronny Trummer; Worranan Rangsimawong; Warayuth Sajomsang; Mont Kumpugdee-Vollrath; Praneet Opanasopit; Prasopchai Tonglairoum
Journal:  RSC Adv       Date:  2018-06-22       Impact factor: 4.036

2.  Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme.

Authors:  Yu-Ling Lin; Kai-Fu Chang; Xiao-Fan Huang; Che-Lun Hung; Shyh-Chang Chen; Wan-Ru Chao; Kuang-Wen Liao; Nu-Man Tsai
Journal:  Int J Nanomedicine       Date:  2015-09-28

3.  Polysaccharide-based micelles for drug delivery.

Authors:  Nan Zhang; Patricia R Wardwell; Rebecca A Bader
Journal:  Pharmaceutics       Date:  2013-05-27       Impact factor: 6.321

4.  N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors.

Authors:  Chun-ge Zhang; Qiao-ling Zhu; Yi Zhou; Yang Liu; Wei-liang Chen; Zhi-Qiang Yuan; Shu-di Yang; Xiao-feng Zhou; Ai-jun Zhu; Xue-nong Zhang; Yong Jin
Journal:  Int J Nanomedicine       Date:  2014-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.